|Articles|March 6, 2006

EU Innovation and Competitiveness

Program Co-Chairs Iman Barilero, Johnson & Johnson PRD, and Marie Dray, International Regulatory Affairs Group USA, opened the first plenary session with introductions, sharing their vision of what the 18th Annual DIA EuroMeeting is all about: continuing themes throughout the meeting, including pediatrics, advanced therapies, technology platform, pharmacovigilance, risk management planning, and the involvement of patient groups.

Marie Dray mentioned that the EuroMeeting will continue Afssaps, involve patient groups, and develop the European Forum-asking regulators questions and discussing what is optimal regulation. Iman Barilero discussed the overall theme of the current environment for innovation and competitiveness in Europe.

Articles in this issue

over 19 years ago

Article

entimo AG Ushers in New Era of Clinical Data Repository-Based Data Analysis and Reporting Environments

over 19 years ago

Article

Fighting for Europe's Future

over 19 years ago

Article

Biophage Pharma Signs an Exclusive Licensing Agreement with Melisa Diagnostics Ltd.

over 19 years ago

Article

Oracle Introduces Oracle® Clinical Data Repository

over 19 years ago

Article

Cognitive Drug Research Signs Development Agreement With Pharma Services Network

over 19 years ago

Article

Interview with Klaus Rose

over 19 years ago

Article

Phase Forward Shows Strong Presence at DIA 18th Annual EuroMeeting Conference

over 19 years ago

Article

Medidata Solutions to Provide Clinical Data Management Expertise at 18th Annual DIA EuroMeeting

over 19 years ago

Article

Pictures from Paris

over 19 years ago

Article

PRA International Names Dr. Cynthia Kirk Vice President of Global Regulatory Affairs

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!